Wuhan Hiteck Biological Pharma Co (SZSE:300683) 3-Year Book Growth Rate : 4.60% (As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co 3-Year Book Growth Rate?

Wuhan Hiteck Biological Pharma Co's Book Value per Share for the quarter that ended in Jun. 2024 was ¥18.76.

During the past 12 months, Wuhan Hiteck Biological Pharma Co's average Book Value per Share Growth Rate was -5.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was 4.60% per year. During the past 5 years, the average Book Value per Share Growth Rate was 3.30% per year. During the past 10 years, the average Book Value per Share Growth Rate was 15.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 11 years, the highest 3-Year average Book Value per Share Growth Rate of Wuhan Hiteck Biological Pharma Co was 31.60% per year. The lowest was 1.50% per year. And the median was 14.15% per year.

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate falls into.

Wuhan Hiteck Biological Pharma Co 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Wuhan Hiteck Biological Pharma Co (SZSE:300683) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Wuhan Hiteck Biological Pharma Co 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Wuhan Hiteck Biological Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » 3-Year Book Growth Rate

Traded in Other Exchanges

N/A

Address

Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056

Website

http://www.hiteck.com.cn

Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.

Executives

Yan Jie	Director
Li Sheng Qiang	Executives

Wuhan Hiteck Biological Pharma Co Headlines

No Headlines